Vincerx Pharma, Inc. (VINC)
NASDAQ: VINC · Real-Time Price · USD
0.259
-0.017 (-6.04%)
Nov 21, 2024, 3:49 PM EST - Market open

Vincerx Pharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Equivalents
2.9412.7811.66111.4661.79-
Short-Term Investments
7.14-40.8---
Cash & Short-Term Investments
10.0912.7852.46111.4661.79-
Cash Growth
-51.51%-75.63%-52.93%80.38%--
Other Receivables
1.061.291.37---
Receivables
1.061.291.37---
Prepaid Expenses
0.280.050.130.181.1-
Restricted Cash
0.090.070.070.11--
Other Current Assets
0.230.531.930.10.21-
Total Current Assets
11.7514.7355.96111.8463.11-
Property, Plant & Equipment
1.522.333.244.18--
Other Long-Term Assets
1.681.160.081.650.08-
Total Assets
14.9518.2259.29117.6863.19-
Accounts Payable
1.962.54.072.020.490.04
Accrued Expenses
1.721.763.924.725-
Current Portion of Leases
1.271.161.020.74--
Other Current Liabilities
0.460.190.146.4532.320.01
Total Current Liabilities
5.425.619.1613.9237.810.04
Long-Term Leases
0.371.342.413.44--
Other Long-Term Liabilities
0.050.050.05---
Total Liabilities
5.84711.6217.3637.810.04
Common Stock
000000
Additional Paid-In Capital
190.19170.32166.65156.3142.040
Retained Earnings
-181.19-159.11-118.96-55.97-16.67-0.05
Comprehensive Income & Other
0.10.01-0.03-0.02--0
Shareholders' Equity
9.1111.2247.67100.3225.38-0.04
Total Liabilities & Equity
14.9518.2259.29117.6863.19-
Total Debt
1.642.53.444.17--
Net Cash (Debt)
8.4510.2849.02107.2961.79-
Net Cash Growth
-53.17%-79.03%-54.31%73.62%--
Net Cash Per Share
0.270.482.336.2511.77-
Filing Date Shares Outstanding
33.5621.4121.2521.0613.989.33
Total Common Shares Outstanding
21.4121.4121.2421.0613.989.33
Working Capital
6.329.1346.8197.9225.3-0.04
Book Value Per Share
0.430.522.244.761.81-0.00
Tangible Book Value
9.1111.2247.67100.3225.38-0.04
Tangible Book Value Per Share
0.430.522.244.761.81-0.00
Machinery
-0.260.260.26--
Source: S&P Capital IQ. Standard template. Financial Sources.